Virginia Cancer Specialists, PC

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Metastatic breast cancer2 trials
• Cervical cancer1 trial
• Gastric and oesophageal cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Mesothelioma1 trial

Phase

• Phase 33 trials
• Phase 1/22 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting4 trials
• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Pfizer4 trials
• Incyte Corporation1 trial
• Seagen, a wholly owned subsidiary of Pfizer1 trial
• Vivace Therapeutics, Inc1 trial

Running trials

• Recruiting

  Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  NCT07392892· Phase 2/3· Pfizer· Source

• Recruiting

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  NCT07222800· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

  NCT06966453· Phase 1/2· Pfizer· Source

• Recruiting

  Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

  NCT04665206· Phase 1/2· Vivace Therapeutics, Inc· Source

  Contact: Heather Fritz

• Active, not recruiting

  Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

  NCT04579380· Phase 2· Seagen, a wholly owned subsidiary of Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Mesothelioma1 recruiting
• Metastatic breast cancer1 recruiting

Closed trials

• Completed

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· Phase 3· Incyte Corporation· Source